Ilan Zipkin, PH.D.
Senior Investment Director of Takeda Ventures
Dr. Zipkin is Senior Investment Director at Takeda Ventures, Inc., having been involved in biotechnology and pharmaceutical venture capital since 2000. He was previously a Partner at the institutional venture firms Prospect Venture Partners and MPM Capital, where he focused on investments in therapeutics companies as well as platform technologies. In addition to serving on the Board of several private and public biotechnology companies, Dr. Zipkin served as the CEO of Chimeros, Inc., a protein-based system for the development of multivalent biologic therapeutics. Prior to his venture capital experience, Dr. Zipkin was the Science Editor of BioCentury Publications Inc., a biotechnology news and analysis publication. He received a Ph.D. in cell biology and biochemistry from the University of California at San Francisco (UCSF), and a B.A. in Molecular and Cell Biology from U.C. Berkeley.